Logo image of BHG

BRIGHT HEALTH GROUP INC (BHG) Stock Fundamental Analysis

NYSE:BHG - New York Stock Exchange, Inc. - US10920V4041 - Common Stock - Currency: USD

16.35  +1.4 (+9.36%)

Fundamental Rating

2

Taking everything into account, BHG scores 2 out of 10 in our fundamental rating. BHG was compared to 108 industry peers in the Health Care Providers & Services industry. BHG may be in some trouble as it scores bad on both profitability and health. BHG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BHG has reported negative net income.
BHG had a negative operating cash flow in the past year.
In the past 5 years BHG always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: BHG reported negative operating cash flow in multiple years.
BHG Yearly Net Income VS EBIT VS OCF VS FCFBHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -79.71%, BHG is doing worse than 90.43% of the companies in the same industry.
Industry RankSector Rank
ROA -79.71%
ROE N/A
ROIC N/A
ROA(3y)-26.23%
ROA(5y)N/A
ROE(3y)-110.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHG Yearly ROA, ROE, ROICBHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BHG Yearly Profit, Operating, Gross MarginsBHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

BHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BHG has about the same amount of shares outstanding.
Compared to 1 year ago, BHG has a worse debt to assets ratio.
BHG Yearly Shares OutstandingBHG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M
BHG Yearly Total Debt VS Total AssetsBHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of -1.98, we must say that BHG is in the distress zone and has some risk of bankruptcy.
BHG has a worse Altman-Z score (-1.98) than 81.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.98
ROIC/WACCN/A
WACC6.5%
BHG Yearly LT Debt VS Equity VS FCFBHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.09 indicates that BHG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.09, BHG is doing worse than 66.09% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that BHG should not have too much problems paying its short term obligations.
BHG has a Quick ratio of 1.09. This is comparable to the rest of the industry: BHG outperforms 40.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
BHG Yearly Current Assets VS Current LiabilitesBHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

BHG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.41%, which is quite impressive.
BHG shows a strong growth in Revenue. In the last year, the Revenue has grown by 367.50%.
Measured over the past years, BHG shows a very strong growth in Revenue. The Revenue has been growing by 104.82% on average per year.
EPS 1Y (TTM)47.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.68%
Revenue 1Y (TTM)367.5%
Revenue growth 3Y104.82%
Revenue growth 5YN/A
Sales Q2Q%39.3%

3.2 Future

Based on estimates for the next years, BHG will show a very strong growth in Earnings Per Share. The EPS will grow by 24.13% on average per year.
Based on estimates for the next years, BHG will show a very negative growth in Revenue. The Revenue will decrease by -15.72% on average per year.
EPS Next Y25.96%
EPS Next 2Y38.14%
EPS Next 3Y24.13%
EPS Next 5YN/A
Revenue Next Year-45.23%
Revenue Next 2Y-27.55%
Revenue Next 3Y-15.72%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHG Yearly Revenue VS EstimatesBHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
BHG Yearly EPS VS EstimatesBHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BHG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHG Price Earnings VS Forward Price EarningsBHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHG Per share dataBHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 -200

4.3 Compensation for Growth

A more expensive valuation may be justified as BHG's earnings are expected to grow with 24.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.14%
EPS Next 3Y24.13%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BHG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIGHT HEALTH GROUP INC

NYSE:BHG (1/26/2024, 8:04:13 PM)

16.35

+1.4 (+9.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2023-11-07/bmo
Earnings (Next)03-01 2024-03-01/amc
Inst Owners65.17%
Inst Owner Change-99.42%
Ins Owners1738.12%
Ins Owner Change0%
Market Cap130.47M
Analysts49.09
Price Target27.2 (66.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-33.04%
Min EPS beat(2)-93.71%
Max EPS beat(2)27.63%
EPS beat(4)2
Avg EPS beat(4)-29.92%
Min EPS beat(4)-93.71%
Max EPS beat(4)33.99%
EPS beat(8)2
Avg EPS beat(8)-51.14%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-33.49%
Min Revenue beat(2)-60.77%
Max Revenue beat(2)-6.22%
Revenue beat(4)1
Avg Revenue beat(4)-30.07%
Min Revenue beat(4)-61.47%
Max Revenue beat(4)8.17%
Revenue beat(8)1
Avg Revenue beat(8)-79.17%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-293.09%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)13.29%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-54.11
EYN/A
EPS(NY)-11.81
Fwd EYN/A
FCF(TTM)-285.84
FCFYN/A
OCF(TTM)-284.79
OCFYN/A
SpS345.44
BVpS-16.62
TBVpS-28.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.23%
ROA(5y)N/A
ROE(3y)-110.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.54%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z -1.98
F-Score3
WACC6.5%
ROIC/WACCN/A
Cap/Depr(3y)72.7%
Cap/Depr(5y)72.16%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.68%
EPS Next Y25.96%
EPS Next 2Y38.14%
EPS Next 3Y24.13%
EPS Next 5YN/A
Revenue 1Y (TTM)367.5%
Revenue growth 3Y104.82%
Revenue growth 5YN/A
Sales Q2Q%39.3%
Revenue Next Year-45.23%
Revenue Next 2Y-27.55%
Revenue Next 3Y-15.72%
Revenue Next 5YN/A
EBIT growth 1Y-91.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.46%
EBIT Next 3Y26.39%
EBIT Next 5YN/A
FCF growth 1Y-1745.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1480.68%
OCF growth 3YN/A
OCF growth 5YN/A